{"id":{"repo_id":"birmingham","oai_identifier":"oai:etheses.bham.ac.uk:6481"},"canonical_url":"https://search.ndltd.org/etd/birmingham/oai:etheses.bham.ac.uk:6481","repository":{"repo_id":"birmingham","name":"University of Birmingham","base_url":"https://etheses.bham.ac.uk/cgi/oai2"},"display":{"title":"Quality of life in newly diagnosed bladder cancer patients","abstract":"It has been postulated that bladder cancer impacts health-related quality of life (HRQoL),but research is limited. This research is particularly important as survival for non-muscle invasive bladder cancer (NMIBC) is high, and these patients will need to live with acceptable HRQoL for many years. I investigated HRQoL in 1258 muscle invasive bladder cancer (MIBC) and NMIBC patients participating in the Bladder Cancer Prognosis Programme. Although I found no major difference in HRQoL around time of diagnosis between NMIBC and MIBC patients, I did find that different parts of HRQoL seemed to influence survival of NMIBC and MIBC. Also, patients prefer an invasive but accurate cystoscopy over a hypothetical non- invasive but less accurate urinary biomarker. Additionally, the European Organization of Research and Treatment of Cancer (EORTC) developed a quality of life questionnaire specifically for NMIBC (EORTC NMIBC-24). In this thesis, I have strengthened the structure of this questionnaire that was previously published by another UK research group. Finally, I found only a small difference in physical health between patients with incontinent and continent urinary diversion in a meta-analysis. These findings were discussed in each of the results chapters, and put into wider context in the general discussion chapter.","abstract_html":"It has been postulated that bladder cancer impacts health-related quality of life (HRQoL),but research is limited. This research is particularly important as survival for non-muscle invasive bladder cancer (NMIBC) is high, and these patients will need to live with acceptable HRQoL for many years. I investigated HRQoL in 1258 muscle invasive bladder cancer (MIBC) and NMIBC patients participating in the Bladder Cancer Prognosis Programme. Although I found no major difference in HRQoL around time of diagnosis between NMIBC and MIBC patients, I did find that different parts of HRQoL seemed to influence survival of NMIBC and MIBC. Also, patients prefer an invasive but accurate cystoscopy over a hypothetical non- invasive but less accurate urinary biomarker. Additionally, the European Organization of Research and Treatment of Cancer (EORTC) developed a quality of life questionnaire specifically for NMIBC (EORTC NMIBC-24). In this thesis, I have strengthened the structure of this questionnaire that was previously published by another UK research group. Finally, I found only a small difference in physical health between patients with incontinent and continent urinary diversion in a meta-analysis. These findings were discussed in each of the results chapters, and put into wider context in the general discussion chapter.","abstract_has_math":false,"creators":["Nekeman, Duncan"],"institution":"University of Birmingham","degree_name":"d_ph","degree_level":"d_ph","degree_discipline":null,"degree_department":null,"school":null,"contributors":[],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2016,"date_issued":"2016-07","date_published":"2016-07","updated_at":"2026-11-19T09:28:55Z","subjects":["RC0254 Neoplasms. Tumors. Oncology (including Cancer)"],"languages":["eng"],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[]},"links":{"outbound_url":null,"outbound_label":null,"outbound_source":null,"record_url":null,"record_label":null,"record_kind":null,"record_source":null,"download_url":"http://etheses.bham.ac.uk//id/eprint/6481/1/Nekeman16PhD_Redacted.pdf","download_label":"Download PDF","download_source":"dc:identifier.uri","access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://etheses.bham.ac.uk/cgi/oai2?verb=GetRecord&metadataPrefix=uketd_dc&identifier=oai%3Aetheses.bham.ac.uk%3A6481","prefix":"uketd_dc"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.sponsor","label":"Sponsor","values":["na"]},{"key":"dc:creator","label":"Author","values":["Nekeman, Duncan"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2016-07"]},{"key":"dc:date.issued","label":"Date","values":["2016-07"]},{"key":"dc:publisher.department","label":"Dc Publisher Department","values":["College of Medical & Dental Sciences","School of Health and Population Studies, Department of Public Health, Epidemiology and Biostatictics"]},{"key":"dc:publisher.institution","label":"Dc Publisher Institution","values":["University of Birmingham"]},{"key":"dc:relation.isreferencedby","label":"Dc Relation Isreferencedby","values":["http://etheses.bham.ac.uk//id/eprint/6481/"]},{"key":"dc:type","label":"Dc Type","values":["Thesis"]},{"key":"dc:type.qualificationlevel","label":"Dc Type Qualificationlevel","values":["d_ph"]},{"key":"dc:type.qualificationname","label":"Dc Type Qualificationname","values":["d_ph"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["RC0254 Neoplasms. Tumors. Oncology (including Cancer)"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language.dcterms_iso639_2","label":"Language (ISO 639-2)","values":["eng"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["http://etheses.bham.ac.uk//id/eprint/6481/1/Nekeman16PhD_Redacted.pdf","http://etheses.bham.ac.uk//id/eprint/6481/2/Decl_IS_Nekeman16PhD.pdf"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["It has been postulated that bladder cancer impacts health-related quality of life (HRQoL),but research is limited. This research is particularly important as survival for non-muscle invasive bladder cancer (NMIBC) is high, and these patients will need to live with acceptable HRQoL for many years. I investigated HRQoL in 1258 muscle invasive bladder cancer (MIBC) and NMIBC patients participating in the Bladder Cancer Prognosis Programme. Although I found no major difference in HRQoL around time of diagnosis between NMIBC and MIBC patients, I did find that different parts of HRQoL seemed to influence survival of NMIBC and MIBC. Also, patients prefer an invasive but accurate cystoscopy over a hypothetical non- invasive but less accurate urinary biomarker. Additionally, the European Organization of Research and Treatment of Cancer (EORTC) developed a quality of life questionnaire specifically for NMIBC (EORTC NMIBC-24). In this thesis, I have strengthened the structure of this questionnaire that was previously published by another UK research group. Finally, I found only a small difference in physical health between patients with incontinent and continent urinary diversion in a meta-analysis. These findings were discussed in each of the results chapters, and put into wider context in the general discussion chapter."]},{"key":"dc:format","label":"Dc Format","values":["application/pdf"]},{"key":"dcterms:accessrights","label":"Dcterms Accessrights","values":["public","staffonly"]},{"key":"dc:title","label":"Title","values":["Quality of life in newly diagnosed bladder cancer patients"]}]}],"canonical_facts":{"dc:contributor.sponsor":["na"],"dc:creator":["Nekeman, Duncan"],"dc:date":["2016-07"],"dc:date.issued":["2016-07"],"dc:description.abstract":["It has been postulated that bladder cancer impacts health-related quality of life (HRQoL),but research is limited. This research is particularly important as survival for non-muscle invasive bladder cancer (NMIBC) is high, and these patients will need to live with acceptable HRQoL for many years. I investigated HRQoL in 1258 muscle invasive bladder cancer (MIBC) and NMIBC patients participating in the Bladder Cancer Prognosis Programme. Although I found no major difference in HRQoL around time of diagnosis between NMIBC and MIBC patients, I did find that different parts of HRQoL seemed to influence survival of NMIBC and MIBC. Also, patients prefer an invasive but accurate cystoscopy over a hypothetical non- invasive but less accurate urinary biomarker. Additionally, the European Organization of Research and Treatment of Cancer (EORTC) developed a quality of life questionnaire specifically for NMIBC (EORTC NMIBC-24). In this thesis, I have strengthened the structure of this questionnaire that was previously published by another UK research group. Finally, I found only a small difference in physical health between patients with incontinent and continent urinary diversion in a meta-analysis. These findings were discussed in each of the results chapters, and put into wider context in the general discussion chapter."],"dc:format":["application/pdf"],"dc:identifier.uri":["http://etheses.bham.ac.uk//id/eprint/6481/1/Nekeman16PhD_Redacted.pdf","http://etheses.bham.ac.uk//id/eprint/6481/2/Decl_IS_Nekeman16PhD.pdf"],"dc:language.dcterms_iso639_2":["eng"],"dc:publisher.department":["College of Medical & Dental Sciences","School of Health and Population Studies, Department of Public Health, Epidemiology and Biostatictics"],"dc:publisher.institution":["University of Birmingham"],"dc:relation.isreferencedby":["http://etheses.bham.ac.uk//id/eprint/6481/"],"dc:subject":["RC0254 Neoplasms. Tumors. Oncology (including Cancer)"],"dcterms:accessrights":["public","staffonly"],"dc:title":["Quality of life in newly diagnosed bladder cancer patients"],"dc:type":["Thesis"],"dc:type.qualificationlevel":["d_ph"],"dc:type.qualificationname":["d_ph"]},"updated_at":"2026-11-19T09:28:55Z"}